William F. Doyle

2018

In 2018, William F. Doyle earned a total compensation of $4.6M as Executive Chairman at NovoCure, a 81% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$843,750
Option Awards$2,359,400
Salary$750,000
Stock Awards$587,505
Other$18,000
Total$4,558,655

Doyle received $2.4M in option awards, accounting for 52% of the total pay in 2018.

Doyle also received $843.8K in non-equity incentive plan, $750K in salary, $587.5K in stock awards and $18K in other compensation.

Rankings

In 2018, William F. Doyle's compensation ranked 2,303rd out of 14,244 executives tracked by ExecPay. In other words, Doyle earned more than 83.8% of executives.

ClassificationRankingPercentile
All
2,303
out of 14,244
84th
Division
Manufacturing
843
out of 5,758
85th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
99
out of 849
88th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
47
out of 547
91st
Industry
Surgical and Medical Instruments and Apparatus
25
out of 348
93rd
Source: SEC filing on April 10, 2019.

Doyle's colleagues

We found five more compensation records of executives who worked with William F. Doyle at NovoCure in 2018.

2018

Asaf Danziger

NovoCure

Chief Executive Officer

2018

Wilhelmus Groenhuysen

NovoCure

Chief Financial Officer

2018

Eilon Kirson

NovoCure

Chief Scientific Officer

2018

Pritesh Shah

NovoCure

Chief Commercial Officer

2018

Michael Ambrogi

NovoCure

Chief Operating Officer

News

In-depth

You may also like